Lloyd D. Fisher

Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B

Greg Brown, John J. Albers, Lloyd D. Fisher et al. · New England Journal of Medicine · 1990 · 2.2K citations · Full text

Medicine, Cardiology, Pharmacology +17

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

Salim Yusuf, David M. Zucker, Eugene R. Passamani et al. · The Lancet · 1994 · 2.1K citations

Medicine, Cardiology, Surgery +6

Aneurysmal coronary artery disease.

Paul S. Swaye, Lloyd D. Fisher, Paul E. Litwin et al. · Circulation · 1983 · 1K citations · Full text

Medicine, Cardiology, Surgery +14

Regimen-related toxicity in patients undergoing bone marrow transplantation.

Scott I. Bearman, F R Appelbaum, CD Buckner et al. · Journal of Clinical Oncology · 1988 · 878 citations

Medicine, Oncology, Chemotherapy +16

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand, Lloyd D. Fisher, YannTong Chiang et al. · Circulation · 2003 · 861 citations

Medicine, Cardiology, Pharmacology +12